In utero CRISPR-mediated therapeutic editing of metabolic genes …………… Rossidis AC, Stratigis JD, Chadwick AC, Hartman HA, Ahn NJ, Li H, Singh K, Coons BE, Li L, Lv W, Zoltick PW, Alapati D, Zacharias W, Jain R, Morrisey EE, Musunuru K, Peranteau WH. Nat Med. 2018 Oct;24(10):1513-1518. PubMed 00
Genetic Modulation of RNA Splicing with a CRISPR-Guided Cytidine Deaminase …………… Yuan J, Ma Y, Huang T, Chen Y, Peng Y, Li B, Li J, Zhang Y, Song B, Sun X, Ding Q, Song Y, Chang X. Mol Cell. 2018 Oct 18;72(2):380-394.e7. PubMed 00
Several structural motifs cooperate in determining the highly effective anti-thrombin activity of NU172 aptamer …………… Troisi R, Napolitano V, Spiridonova V, Russo Krauss I, Sica F. Nucleic Acids Res. 2018 Oct 24. PubMed 00
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a therapeutic target …………… Wei J, Marisetty A, Schrand B, Gabrusiewicz K, Hashimoto Y, Ott M, Grami Z, Kong LY, Ling X, Caruso HG, Zhou S, Wang YA, Fuller GN, Huse JT, Gilboa E, Kang N, Huang X, Verhaak R, Li S, Heimberger AB. J Clin Invest. 2018…